Clevudine Capsule(Guangxi Huibaoyuan Pharma)

克来夫定胶囊(广西慧宝源医药)

Report date: 2025/08/29 20:01:31

Base Information

Drug NameClevudine Capsule(Guangxi Huibaoyuan Pharma)
Drug Alias Nameclevudinum克力夫定clevudina克来夫定克立夫定 +[7
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG